Was Manus another DeepSeek moment? Chinese AI agent faces doubts after rapid rise to fame

Full Article
Was Manus another DeepSeek moment? Chinese AI agent faces doubts after rapid rise to fame

Manus, a general-purpose AI agent developed by a Chinese team, is under scrutiny due to doubts about its technological capabilities. Following a surge in popularity, the product faced server capacity issues, limiting user access just a day after its launch. Investors initially hailed Manus as a breakthrough similar to DeepSeek, but its availability remains restricted.

The launch's invitation-only model led to a scramble for access, with some users selling invitation codes on second-hand platforms. Manus AI's product partner acknowledged underestimating public enthusiasm and admitted that server resources were only meant for demonstration purposes. The current version of Manus is still in development, and the team is working to resolve issues related to their suspended social media account.

• Manus AI faces doubts due to limited testing and server capacity issues.

• The product's popularity led to an invitation-only access model and account suspensions.

Key AI Terms Mentioned in this Article

General-purpose AI

General-purpose AI refers to systems designed to perform a wide range of tasks, as seen with Manus.

Server capacity

Server capacity indicates the amount of data and user requests a server can handle, which Manus struggled with post-launch.

Scarcity marketing

Scarcity marketing is a strategy that creates demand by limiting availability, which critics accused Manus of employing.

Companies Mentioned in this Article

Manus AI

Manus AI is the developer of the Manus agent, which aims to handle complex tasks but faced server issues.

DeepSeek

DeepSeek is recognized for its low-cost AI models, which investors compare to Manus's capabilities.

Get Email Alerts for AI News

By creating an email alert, you agree to AIleap's Terms of Service and Privacy Policy. You can pause or unsubscribe from email alerts at any time.

Latest Articles

Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive
TechCrunch 6month

Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600

AI In Education - Up-level Your Teaching With AI By Cloning Yourself
Forbes 6month

How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.

Trump's Third Term - How AI Can Help To Overthrow The US Government
Forbes 6month

Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.

Sam Altman Says OpenAI Will Release an 'Open Weight' AI Model This Summer
Wired 6month

Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.

Popular Topics